-66.8%
NKE vs THC
+318.9%
-385.7%
-71.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.1% | -0.2% | -4.0% | -4.1% |
| 7D | -13.3% | -8.0% | -5.4% | -12.3% |
| 30D | -12.3% | -2.2% | -10.1% | -12.0% |
| 3M | -17.3% | -3.5% | -13.8% | -16.9% |
| 6M | -24.0% | +40.4% | -64.5% | -27.3% |
| YTD | -47.0% | +32.4% | -79.4% | -49.1% |
| 1Y | -44.6% | +41.0% | -85.6% | -47.5% |
| 3Y | -66.8% | +305.2% | -372.0% | -74.1% |
| All | -66.8% | +318.9% | -385.7% | -74.1% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling